"Triglycerides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D014280
|
| MeSH Number(s) |
D10.351.801
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Triglycerides".
Below are MeSH descriptors whose meaning is more specific than "Triglycerides".
This graph shows the total number of publications written about "Triglycerides" by people in this website by year, and whether "Triglycerides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 2 | 4 | 6 |
| 1997 | 1 | 2 | 3 |
| 1998 | 0 | 2 | 2 |
| 1999 | 2 | 2 | 4 |
| 2000 | 1 | 3 | 4 |
| 2001 | 5 | 11 | 16 |
| 2002 | 3 | 4 | 7 |
| 2003 | 4 | 13 | 17 |
| 2004 | 4 | 12 | 16 |
| 2005 | 6 | 7 | 13 |
| 2006 | 4 | 13 | 17 |
| 2007 | 4 | 6 | 10 |
| 2008 | 9 | 8 | 17 |
| 2009 | 7 | 11 | 18 |
| 2010 | 3 | 14 | 17 |
| 2011 | 6 | 14 | 20 |
| 2012 | 6 | 19 | 25 |
| 2013 | 10 | 19 | 29 |
| 2014 | 10 | 18 | 28 |
| 2015 | 5 | 10 | 15 |
| 2016 | 7 | 8 | 15 |
| 2017 | 6 | 12 | 18 |
| 2018 | 5 | 2 | 7 |
| 2019 | 8 | 14 | 22 |
| 2020 | 1 | 12 | 13 |
| 2021 | 5 | 6 | 11 |
| 2022 | 0 | 11 | 11 |
| 2023 | 0 | 7 | 7 |
| 2024 | 7 | 8 | 15 |
| 2025 | 0 | 7 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Triglycerides" by people in Profiles.
-
Visit-to-visit lipid variability, coronary artery calcification, inflammation, and mortality in the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2025 Sep 22; 32(13):1235-1244.
-
Trends in blood-based metabolic and cardiovascular risk profiles in men during treatment for testosterone deficiency: a longitudinal, retrospective cohort study. J Sex Med. 2025 Sep 04; 22(9):1564-1571.
-
Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis. EBioMedicine. 2025 Aug; 118:105840.
-
Functional regulation of macrophages by Ces1d-mediated lipid signaling in immunometabolism. Mol Metab. 2025 Jul; 97:102166.
-
Epidemiology and longitudinal course of chylomicronemia: Insights from NHANES and a large health care system. J Clin Lipidol. 2025 May-Jun; 19(3):432-441.
-
Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and?Number?in?Hypertriglyceridemia. J Am Coll Cardiol. 2025 May 20; 85(19):1839-1854.
-
Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA. Atherosclerosis. 2025 04; 403:119114.
-
The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes. Lipids Health Dis. 2024 Dec 23; 23(1):416.
-
High LDL Particle and APOB Concentrations in Patients With Adrenal Cortical Adenomas. J Clin Endocrinol Metab. 2024 Dec 18; 110(1):195-207.
-
Genetic Variants in Severe Hypertriglyceridemia Among Taiwanese Participants - Insights From Genome-Wide Association and Whole-Exome Sequencing Analyses. Circ J. 2025 Feb 25; 89(3):331-339.